Zoetis Inc. (ZTS) Stock Price & Analysis
Zoetis Inc. (ZTS) fell 0.63% to USD 75.81 as of September 8, 2026 at 02:53 UTC, according to Nexqual real-time market data.
ZTS last closed at USD 75.81; the session ranged USD 74.83–75.84 on volume of 3,985,628 shares. Market capitalization is —, with a 52-week range of USD 71–152.12 (NYQ). Source: Nexqual, September 8, 2026 at 02:53 UTC.
Key Statistics (as of September 8, 2026 at 02:53 UTC)
| Price | USD 75.81 |
|---|---|
| Change | ▼ 0.63% (down) |
| Previous Close | USD 75.81 |
| Open | USD 75.81 |
| Day Range | USD 74.83 – 75.84 |
| 52-Week Range | USD 71 – 152.12 |
| Volume | 3,985,628 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (ZTS)
Nexqual's technical model rates ZTS "NEUTRAL" based on 2 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 02:53 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.52 (neutral) |
| vs SMA50 | Above (USD 75.58) |
| MACD | 0.15 (positive) |
From Zoetis Inc.'s Latest SEC 10-K Filing (filed 2026-02-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Zoetis enhanced the portfolio of its diagnostic products with the acquisition in 2018 of Abaxis, Inc. (Abaxis), a leading provider of veterinary point-of-care diagnostic instruments, including the Vetscan ® portfolio of benchtop and handheld diagnostic instruments and consumables.
Partnerships
- In 2024, the company started a collaboration with Blacksmith Medicines to discover and develop novel antibiotics for animal health and provide new options for our customers to treat life-threatening infections in livestock.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IDXX | IDEXX Laboratories, Inc. | USD 535.38 | ▼ 0.67% |
| TMO | Thermo Fisher Scientific Inc | USD 613.78 | ▲ 0.86% |
| DHR | Danaher Corporation | USD 207.66 | ▼ 1.07% |
| SPGI | S&P Global Inc. | USD 443.51 | ▲ 2.73% |
| EW | Edwards Lifesciences Corporatio | USD 89.9 | ▼ 1.01% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:53 UTC. This page is informational and not investment advice.